Live Quote · NASDAQBLTEHealthcare· Biotechnology

Belite Bio, Inc

$127.38▼ 15.65%($-23.64)
MKT CAP $5.17BNEXT EARNINGS Mar 1, 2027
50%
Bullish
TickerSpark Score
36/100
▌ Weak
60
Valuation
20
Profitability
15
Growth
56
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BLTE research report →

Analyst Price Target
$245.17+92.5% vs. today

Range $206 – $303

Analyst RatingBuy
6 Buy0 Hold0 Sell

Price Chart

+25.46% · this period
$193.61$151.40$109.18Nov 19May 22Nov 19
52-Week Range21% of range
Low
$108.00
Current
$127.38
High
$200.00